The APIS Team will be exhibiting and presenting at the 13th Clinical Biomarkers & CDx Europe 2023 in London.
Be sure not to miss our Chief Operating Officer, Ian Kavanagh, presenting on Day 1 at 9:50 AM in the plenary session with his talk titled ‘HER2 Stratification with a Novel Diagnostic Test’.
Discovering the potential of the APIS Breast Cancer Subtyping Kit for faster HER2 result turnaround without the need for reflex testing to ISH
Learning how to significantly reduce time for results interpretation with automatic results via validated software
The detection ability of lowly expressed ERBB2 levels aligns the IVD test as a CDx to HER2 targeted therapies, such as Trastuzumab deruxtecan
Interested in learning more? Use this link to contact us and schedule a meeting.